Open AccessCommunity-Acquired Stenotrophomonas Maltophilia Infection in a Child: A Case Report and Literature Review
Author(s) -
Zhihong Jiang,
YiFan Ren,
Chuanxin Zhang,
Yilong Yin,
Chaohui Li
Publication year - 2022
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s376712
Subject(s) - stenotrophomonas maltophilia , medicine , pneumonia , ciprofloxacin , community acquired pneumonia , ceftazidime , meropenem , pediatrics , sulfamethoxazole , antibiotics , blood culture , trimethoprim , intensive care medicine , white blood cell , immunology , microbiology and biotechnology , pseudomonas aeruginosa , antibiotic resistance , biology , bacteria , genetics
Stenotrophomonas maltophilia (S. maltophilia) is a pathogen causing opportunistic and nosocomial infections that are invasive and fatal, especially in hospitalized and immunocompromised patients. However, community-acquired S. maltophilia is rarely reported in children with normal immunity. S. maltophilia is a multi-drug-resistant bacterium, and the preferred drug is trimethoprim/sulfamethoxazole (TMP/SMX), which has greater side effects in children.